The Role of Add-On Lacosamide Therapy in the Treatment of Focal Onset Epilepsy
Objectives:The aim of this study was to retrospectively evaluate the efficacy and safety of lacosamide (200-300-400 mg/day) as adjunct treatment in patients with uncontrolled focal-onset seizures taking 2 or more antiepileptic drugs (AED).Methods:The medical records of patients with uncontrolled foc...
| Published in: | Archives of Epilepsy |
|---|---|
| Main Authors: | Güray KOÇ, Semai BEK, Ömer KARADAŞ, Erdal EROĞLU, Zeki GÖKÇİL |
| Format: | Article |
| Language: | English |
| Published: |
Turkish Epilepsy Society
2017-12-01
|
| Subjects: | |
| Online Access: |
http://archepilepsy.org/archives/archive-detail/article-preview/the-role-of-add-on-lacosamide-therapy-in-the-treat/54950
|
Similar Items
The Effect of Lacosamide Polytherapy on Seizure Prognosis in Focal Epilepsies
by: Mehmet Taylan PEKÖZ, et al.
Published: (2021-09-01)
by: Mehmet Taylan PEKÖZ, et al.
Published: (2021-09-01)
Efficacy of Lacosamide Therapy in Focal Onset Refractory Epilepsy of Childhood: A Single Center Experience
by: Halil Ural Aksoy, et al.
Published: (2021-12-01)
by: Halil Ural Aksoy, et al.
Published: (2021-12-01)
Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
by: Wenyu Liu, et al.
Published: (2023-04-01)
by: Wenyu Liu, et al.
Published: (2023-04-01)
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
by: A. Romigi, et al.
Published: (2014-01-01)
by: A. Romigi, et al.
Published: (2014-01-01)
Lacosamide add-on Treatment in Refractory Focal Epilepsy: The Experience of a Single Tertiary Center
by: Aslı AKYOL GÜRSES, et al.
Published: (2020-08-01)
by: Aslı AKYOL GÜRSES, et al.
Published: (2020-08-01)
Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
by: Chunsong Yang, et al.
Published: (2023-08-01)
by: Chunsong Yang, et al.
Published: (2023-08-01)
The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index
by: V. A. Karlov, et al.
Published: (2020-06-01)
by: V. A. Karlov, et al.
Published: (2020-06-01)
Efficacy of lacosamide add-on therapy on Refractory Focal Epilepsies in children and adolescents: An open-label clinical trial
by: Tayebeh Mohammadi, et al.
Published: (2022-01-01)
by: Tayebeh Mohammadi, et al.
Published: (2022-01-01)
Clinical Experience with Adjunctive Lacosamide in Adult Patients with Focal Seizures
by: Demet İLHAN ALGIN, et al.
Published: (2017-08-01)
by: Demet İLHAN ALGIN, et al.
Published: (2017-08-01)
Short-term Results of The Add-on Lacosamide Therapy in Patients with Drug-resistant Focal Onset Seizures
by: Fulya EREN, et al.
Published: (2021-03-01)
by: Fulya EREN, et al.
Published: (2021-03-01)
Switching carbamazepine to lacosamide improves gamma‐glutamyl transpeptidase levels
by: Yuichi Kubota, et al.
Published: (2024-10-01)
by: Yuichi Kubota, et al.
Published: (2024-10-01)
EFFICACY OF VIMPAT (LACOSAMIDE) TN THE TREATMENT OF DRUG-RESISTANT CRYPTOGENIC FOCAL EPILEPSY WITH FOCAL AUTOMOTOR AND SECONDARILY GENERALIZED SEIZURES (A CLINICAL CASE)
by: M. B. Mironov, et al.
Published: (2015-07-01)
by: M. B. Mironov, et al.
Published: (2015-07-01)
Epilepsy and Military Service
by: Güray KOÇ, et al.
Published: (2017-12-01)
by: Güray KOÇ, et al.
Published: (2017-12-01)
Unmasking of myoclonus by lacosamide in generalized epilepsy
by: Daniel Birnbaum, et al.
Published: (2017-01-01)
by: Daniel Birnbaum, et al.
Published: (2017-01-01)
EFFICACY AND TOLERABILITY OF LACOSAMIDE (VIMPAT) FOR TREATMENT OF EPILEPSY IN ADULTS (A REVIEW)
by: O. A. Pylaeva, et al.
Published: (2015-04-01)
by: O. A. Pylaeva, et al.
Published: (2015-04-01)
Real-Life Efficacy and Tolerability of Lacosamide in Pediatric Patients Aged 4 Years or Older with Drug-Resistant Epilepsy
by: Shin Yun Byun, et al.
Published: (2023-07-01)
by: Shin Yun Byun, et al.
Published: (2023-07-01)
CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY
by: E. A. Pyadushkina, et al.
Published: (2016-12-01)
by: E. A. Pyadushkina, et al.
Published: (2016-12-01)
Clinical Analysis of Lacosamide Monotherapy in the Treatment of Self-Limited Epilepsy with Centrotemporal Spikes
by: Feng J, et al.
Published: (2024-03-01)
by: Feng J, et al.
Published: (2024-03-01)
Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis
by: Chunsong Yang, et al.
Published: (2021-09-01)
by: Chunsong Yang, et al.
Published: (2021-09-01)
Development and validation of a population pharmacokinetic model for lacosamide in adult patients with epilepsy to inform precision dosing
by: Lingyan Yu, et al.
Published: (2026-03-01)
by: Lingyan Yu, et al.
Published: (2026-03-01)
Effect of lacosamide on epileptiform activity and structure-function relations in the brain of rats with chronic focal epilepsy
by: S. A. Litvinova, et al.
Published: (2019-04-01)
by: S. A. Litvinova, et al.
Published: (2019-04-01)
Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database
by: Chang Ge, et al.
Published: (2024-09-01)
by: Chang Ge, et al.
Published: (2024-09-01)
Sudden Unexpected Death in Epilepsy: Two Case Reports
by: Gençer GENÇ, et al.
Published: (2016-12-01)
by: Gençer GENÇ, et al.
Published: (2016-12-01)
Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study
by: Ting Zhao, et al.
Published: (2023-05-01)
by: Ting Zhao, et al.
Published: (2023-05-01)
The therapeutic effects of ketogenic diet, lacosamide, and combination therapy in children with refractory epilepsy
by: Qiming Pang, et al.
Published: (2025-10-01)
by: Qiming Pang, et al.
Published: (2025-10-01)
Saliva-based lacosamide monitoring paves the way toward personalized epilepsy pharmacotherapy
by: Yoonhyuk Jang, et al.
Published: (2025-05-01)
by: Yoonhyuk Jang, et al.
Published: (2025-05-01)
Use of lacosamide in children: experience of a tertiary medical care center in Brazil
by: Tayla Taynan Romão, et al.
Published: (2022-11-01)
by: Tayla Taynan Romão, et al.
Published: (2022-11-01)
Choosing Old and New Antiepileptic Drugs in Epilepsy Treatment
by: Semai Bek, et al.
Published: (2009-06-01)
by: Semai Bek, et al.
Published: (2009-06-01)
Lacosamide Safety During Pregnancy and Breastfeeding: A Single-Centre Experience and Comprehensive Narrative Review
by: Kamila Saramak, et al.
Published: (2026-04-01)
by: Kamila Saramak, et al.
Published: (2026-04-01)
Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis
by: Sonja C. Sawh, et al.
Published: (2013-08-01)
by: Sonja C. Sawh, et al.
Published: (2013-08-01)
Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy
by: Ying-Chi Shen, et al.
Published: (2024-05-01)
by: Ying-Chi Shen, et al.
Published: (2024-05-01)
Lacosamide Increases Absence Seizures and Anxiety-Like Behavior in WAG/Rij Rat Model
by: Orhan Sümbül, et al.
Published: (2022-12-01)
by: Orhan Sümbül, et al.
Published: (2022-12-01)
Real-world safety comparison between cenobamate and lacosamide: a pharmacovigilance study based on the FDA Adverse Event Reporting System
by: Shenglan Shang, et al.
Published: (2025-09-01)
by: Shenglan Shang, et al.
Published: (2025-09-01)
Lacosamide in Pediatric Status Epilepticus
by: Juan A. Piantino
Published: (2017-02-01)
by: Juan A. Piantino
Published: (2017-02-01)
The Efficacy of Lacosamide in the Treatment of Delirium Complicated With Ileus: Four Cases
by: Shinji Sato
Published: (2026-03-01)
by: Shinji Sato
Published: (2026-03-01)
Therapeutic drug monitoring of lacosamide among children: is it helpful?
by: Elkana Kohn, et al.
Published: (2023-07-01)
by: Elkana Kohn, et al.
Published: (2023-07-01)
The Concomitant Effect of the Antiepileptic Drug Lacosamide and rTMS on an SH-SY5Y Model of Neuronal Excitability
by: Ioannis Dardalas, et al.
Published: (2025-09-01)
by: Ioannis Dardalas, et al.
Published: (2025-09-01)
Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients
by: Yan-Ting Lu, et al.
Published: (2022-07-01)
by: Yan-Ting Lu, et al.
Published: (2022-07-01)
Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy
by: Andrea Bianconi, et al.
Published: (2024-01-01)
by: Andrea Bianconi, et al.
Published: (2024-01-01)
Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy Eficácia do clobazam como terapia adjuvante em crianças com epilepsia focal refratária
by: Mariana Ribeiro Marcondes da Silveira, et al.
Published: (2006-09-01)
by: Mariana Ribeiro Marcondes da Silveira, et al.
Published: (2006-09-01)
Similar Items
-
The Effect of Lacosamide Polytherapy on Seizure Prognosis in Focal Epilepsies
by: Mehmet Taylan PEKÖZ, et al.
Published: (2021-09-01) -
Efficacy of Lacosamide Therapy in Focal Onset Refractory Epilepsy of Childhood: A Single Center Experience
by: Halil Ural Aksoy, et al.
Published: (2021-12-01) -
Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
by: Wenyu Liu, et al.
Published: (2023-04-01) -
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
by: A. Romigi, et al.
Published: (2014-01-01) -
Lacosamide add-on Treatment in Refractory Focal Epilepsy: The Experience of a Single Tertiary Center
by: Aslı AKYOL GÜRSES, et al.
Published: (2020-08-01)
